Tag Archives: US Bioservices

QOL Medical Selects Optum Frontier Therapies as New Partner for Sucraid®

QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution

AstraZeneca’s Saphnelo to Compete with GSK’s Benlysta to Treat Lupus

Saphnelo, while primarily available through the leading specialty drug distributors, is also available through Amber Specialty Pharmacy and US Bioservices

RareMed Solutions Providing Non-Commercial Dispensing Services for PTC Therapeutics’ EMFLAZA

RareMed Solutions is the nation’s only (pure) rare and devastating disorder patient service provider (PSP)

AmerisourceBergen selected by Deciphera to support QINLOCK (ripretinib)

AmerisourceBergen’s commercialization support services offer an integrated approach to drug launches

AmerisourceBergen’s Hub Services Support XPOVIO Launch

XPOVIO, from Karyopharm Therapeutics, is the first and only prescription medicine approved in the U.S. for the treatment of multiple myeloma

US Bioservices Expands Rare Disease Distribution

Founded in 1994, US Bioservices began as a regional pharmacy focused on infused therapies. Building on a foundation of patient-centered care, it now provides national in-home nursing services and clinical support for thousands of patients with chronic and complex illnesses. US Bioservices was acquired by AmerisourceBergen in 2003. US Bioservices works in collaboration with other […]